{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:47:06Z","timestamp":1791895626033,"version":"4.3.4"},"reference-count":18,"publisher":"Walter de Gruyter GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_cclm-2026-1298_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Early detection of albuminuria is important for identifying individuals at risk of chronic kidney disease (CKD) progression. Semiquantitative urine albumin-to-creatinine ratio (ACR) strips may serve as an initial laboratory screening or triage tool. However, screening strategies generally apply a single fixed threshold, regardless of patient age. Because CKD prevalence increases with age, a single cut-off does not account for differences in pre-test probability across age groups, potentially resulting in different trade-offs between quantitative confirmation and false-negative classification. We evaluated an age-adjusted threshold approach to improve diagnostic safety while reducing the number of quantitative ACR confirmations required.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_cclm-2026-1298_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Semiquantitative ACR strip results (UC-3500, Sysmex) and quantitative ACR values (Alinity c, Abbott) were collected and analyzed. Diagnostic performance indicators for ACR strip testing were evaluated across different decision thresholds in the overall population and among age groups (18\u201344, 45\u201364 and\u00a0\u226565 years), using quantitative ACR measurement as the reference standard.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_cclm-2026-1298_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Selected thresholds were 30, 30, and 15\u202fmg\/g creatinine for the 18\u201344, 45\u201364, and\u00a0\u226565-year age groups with false omission rates (FOR) of 1.36\u202f%, 3.97\u202f% and 4.47\u202f%, respectively. Overall, the age-stratified strategy yielded a sensitivity of 85.60\u202f%, a NPV of 96.44\u202f% and a FOR of 3.56\u202f%, while avoiding 65.16\u202f% of quantitative ACR measurements.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_cclm-2026-1298_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this retrospective simulation, an age-stratified reflex-testing strategy provided a balance between reducing quantitative ACR measurements and limiting the residual probability of ACR\u00a0\u226530\u202fmg\/g creatinine following a negative semiquantitative result. The strategy used more sensitive thresholds in older patients, in whom albuminuria prevalence was higher, while allowing a greater reduction in quantitative testing in younger groups. These findings were reproducible in a temporal internal validation cohort but require external and local validation before implementation in other laboratories.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/cclm-2026-1298","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:55:54Z","timestamp":1791892554000},"source":"Crossref","is-referenced-by-count":0,"title":["An age-stratified semiquantitative urine ACR triage strategy for quantitative confirmation: a retrospective diagnostic accuracy study with temporal validation"],"prefix":"10.1515","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-7963-9998","authenticated-orcid":false,"given":"Marina","family":"N\u00fa\u00f1ez P\u00e9rez","sequence":"first","affiliation":[{"name":"UGC Laboratorios, Hospital Universitario de Valme, \u00c1rea de Gesti\u00f3n Sanitaria Sur de Sevilla , Sevilla , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6641-2073","authenticated-orcid":false,"given":"Rufino","family":"Mond\u00e9jar","sequence":"additional","affiliation":[{"name":"UGC Laboratorios, Hospital Universitario de Valme, \u00c1rea de Gesti\u00f3n Sanitaria Sur de Sevilla , Sevilla , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Garc\u00e9s Santos","sequence":"additional","affiliation":[{"name":"UGC Laboratorios, Hospital Universitario de Valme, \u00c1rea de Gesti\u00f3n Sanitaria Sur de Sevilla , Sevilla , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda del Mar","family":"Viloria Pe\u00f1as","sequence":"additional","affiliation":[{"name":"UGC Laboratorios, Hospital Universitario de Valme, \u00c1rea de Gesti\u00f3n Sanitaria Sur de Sevilla , Sevilla , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,10,14]]},"reference":[{"key":"2026101311554800770_j_cclm-2026-1298_ref_001","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 2024;105:S117\u2013314."},{"key":"2026101311554800770_j_cclm-2026-1298_ref_002","doi-asserted-by":"crossref","unstructured":"Francis, A, Harhay, MN, Ong, ACM, Tummalapalli, SL, Ortiz, A, Fogo, AB, et al.. Chronic kidney disease and the global public health agenda: an international consensus. Nat Rev Nephrol 2024;20:473\u201385. https:\/\/doi.org\/10.1038\/s41581-024-00820-6.","DOI":"10.1038\/s41581-024-00820-6"},{"key":"2026101311554800770_j_cclm-2026-1298_ref_003","doi-asserted-by":"crossref","unstructured":"GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the global Burden of Disease Study 2019. Lancet [Internet] 2020;396:1204\u201322.","DOI":"10.1016\/S0140-6736(20)30925-9"},{"key":"2026101311554800770_j_cclm-2026-1298_ref_004","doi-asserted-by":"crossref","unstructured":"Ortiz, A, Asociaci\u00f3n Informaci\u00f3n Enfermedades Renales Gen\u00e9ticas (AIRG-E), European Kidney Patients\u2019 Federation (EKPF). Federaci\u00f3n Nacional de Asociaciones para la Lucha Contra las Enfermedades del Ri\u00f1\u00f3n (ALCER), Fundaci\u00f3n Renal \u00cd\u00f1igo \u00c1lvarez de Toledo (FRIAT), Red de Investigaci\u00f3n Renal (REDINREN), Resultados en Salud 2040 (RICORS2040), Sociedad Espa\u00f1ola de Nefrolog\u00eda (SENEFRO) Council, Sociedad Espa\u00f1ola de Trasplante (SET) Council, Organizaci\u00f3n Nacional de Trasplantes (ONT). RICORS2040: the need for collaborative research in chronic kidney disease. Clin Kidney J 2022;15:372\u201387.","DOI":"10.1093\/ckj\/sfab170"},{"key":"2026101311554800770_j_cclm-2026-1298_ref_005","doi-asserted-by":"crossref","unstructured":"Ortiz, A, Mattace-Raso, F, Soler, MJ, Fouque, D. Ageing meets kidney disease. Nephrol Dial Transplant 2023;38:523\u20136. https:\/\/doi.org\/10.1093\/ndt\/gfac199.","DOI":"10.1093\/ndt\/gfac199"},{"key":"2026101311554800770_j_cclm-2026-1298_ref_006","doi-asserted-by":"crossref","unstructured":"Webster, AC, Nagler, EV, Morton, RL, Masson, P. Chronic kidney disease. Lancet 2017;389:1238\u201352. https:\/\/doi.org\/10.1016\/s0140-6736(16)32064-5.","DOI":"10.1016\/S0140-6736(16)32064-5"},{"key":"2026101311554800770_j_cclm-2026-1298_ref_007","doi-asserted-by":"crossref","unstructured":"Santamaria, R, Escobar, C, Aranda, U, Palacios, B, Capel, M, Hern\u00e1ndez, I, et al.. Magnitude of chronic kidney disease in Spain. Nefrologia 2025;45:415\u20139. https:\/\/doi.org\/10.1016\/j.nefro.2024.12.009.","DOI":"10.1016\/j.nefro.2024.12.009"},{"key":"2026101311554800770_j_cclm-2026-1298_ref_008","doi-asserted-by":"crossref","unstructured":"Li\u00e9banas Garc\u00eda, P, Montolio Breva, S, Sans, MT. Evaluation of urine albumin-to-creatinine ratio analysis using strip test as a screening method for urinary albumin determination in primary care. Adv Lab Med 2025;6:345\u201350. https:\/\/doi.org\/10.1515\/almed-2024-0068.","DOI":"10.1515\/almed-2024-0068"},{"key":"2026101311554800770_j_cclm-2026-1298_ref_009","doi-asserted-by":"crossref","unstructured":"Salinas, M, L\u00f3pez-Garrig\u00f3s, M, Flores, E, Lugo, J, Leiva-Salinas, C, PRIMary Care-LABoratory (PRIMLAB) Working Group. Urinary albumin strip assay as a screening test to replace quantitative technology in certain conditions. Clin Chem Lab Med 2018;57:204\u20139. https:\/\/doi.org\/10.1515\/cclm-2018-0546.","DOI":"10.1515\/cclm-2018-0546"},{"key":"2026101311554800770_j_cclm-2026-1298_ref_010","doi-asserted-by":"crossref","unstructured":"Gorostidi, M, S\u00e1nchez-Mart\u00ednez, M, Ruilope, LM, Graciani, A, de la Cruz, JJ, Santamar\u00eda, R, et al.. Prevalencia de enfermedad renal cr\u00f3nica en Espa\u00f1a: impacto de la acumulaci\u00f3n de factores de riesgo cardiovascular. Nefrologia 2018;38:606\u201315.","DOI":"10.1016\/j.nefro.2018.04.004"},{"key":"2026101311554800770_j_cclm-2026-1298_ref_011","doi-asserted-by":"crossref","unstructured":"Lambrecht, S, Speeckaert, M, Oyaert, M. Optimization of screening strategy for chronic kidney disease by urine test strips using the albumin-creatinine read-out. BMC Nephrol 2025;26:130. https:\/\/doi.org\/10.1186\/s12882-025-04048-9.","DOI":"10.1186\/s12882-025-04048-9"},{"key":"2026101311554800770_j_cclm-2026-1298_ref_012","doi-asserted-by":"crossref","unstructured":"Gansevoort, RT, Verhave, JC, Hillege, HL, Burgerhof, JGM, Bakker, SJL, de Zeeuw, D, et al.. The validity of screening based on spot morning urine samples to detect subjects with microalbuminuria in the general population. Kidney Int Suppl 2005;67:S28\u201335. https:\/\/doi.org\/10.1111\/j.1523-1755.2005.09408.x.","DOI":"10.1111\/j.1523-1755.2005.09408.x"},{"key":"2026101311554800770_j_cclm-2026-1298_ref_013","unstructured":"NICE Guidance. Chronic kidney disease: assessment and management [Online]. https:\/\/www.nice.org.uk\/guidance\/ng203 [Accessed 4 Aug 2026]."},{"key":"2026101311554800770_j_cclm-2026-1298_ref_014","unstructured":"Sierra-Rivera, A, Morales-Garc\u00e9s, MM, Villafruela-Rodr\u00edguez-Manzaneque, PJ, M\u00e9ndez-Izquierdo, J, Carmona-Talavera, D, Sahuquillo-Fr\u00edas, L. Evaluation of urinary albumin\/creatinine ratio strip assay: a reliable screening alternative to replacing the quantitative biochemical methods. eJIFCC 2026;37:72\u20137."},{"key":"2026101311554800770_j_cclm-2026-1298_ref_015","doi-asserted-by":"crossref","unstructured":"Oyaert, M, Delanghe, JR. Semiquantitative, fully automated urine test strip analysis. J Clin Lab Anal 2019;33:e22870. https:\/\/doi.org\/10.1002\/jcla.22870.","DOI":"10.1002\/jcla.22870"},{"key":"2026101311554800770_j_cclm-2026-1298_ref_016","doi-asserted-by":"crossref","unstructured":"Bello, AK, Okpechi, IG, Osman, MA, Cho, Y, Htay, H, Jha, V, et al.. Epidemiology of haemodialysis outcomes. Nat Rev Nephrol 2022;18:378\u201395. https:\/\/doi.org\/10.1038\/s41581-022-00542-7.","DOI":"10.1038\/s41581-022-00542-7"},{"key":"2026101311554800770_j_cclm-2026-1298_ref_017","doi-asserted-by":"crossref","unstructured":"Chou, Y-J, Yang, C-C, Chang, S-J, Yang, SS-D. Albuminuria is affected by urinary tract infection: a comparison between biochemical quantitative method and automatic urine chemistry analyzer UC-3500. Diagnostics 2023;13:3366. https:\/\/doi.org\/10.3390\/diagnostics13213366.","DOI":"10.3390\/diagnostics13213366"},{"key":"2026101311554800770_j_cclm-2026-1298_ref_018","doi-asserted-by":"crossref","unstructured":"Delanghe, JR, Himpe, J, De Cock, N, Delanghe, S, De Herde, K, Stove, V, et al.. Sensitive albuminuria analysis using dye-binding based test strips. Clin Chim Acta 2017;471:107\u201312. https:\/\/doi.org\/10.1016\/j.cca.2017.05.032.","DOI":"10.1016\/j.cca.2017.05.032"}],"container-title":["Clinical Chemistry and Laboratory Medicine (CCLM)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/cclm-2026-1298\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/cclm-2026-1298\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:56:17Z","timestamp":1791892577000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/cclm-2026-1298\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,14]]},"references-count":18,"alternative-id":["10.1515\/cclm-2026-1298"],"URL":"https:\/\/doi.org\/10.1515\/cclm-2026-1298","relation":{},"ISSN":["1434-6621","1437-4331"],"issn-type":[{"value":"1434-6621","type":"print"},{"value":"1437-4331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,14]]}}}